Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
standard-of-care imaging (18F-FDG, 68Ga-PSMA, or 68Ga-DOTATATE PET/CT), 68Ga-MY6349 PET/CT
The First People's Hospital of Lianyungang
Tumor
1 trial -
standard-of-care imaging (PSMA/FDG PET/CT), ACP3 PET/CT
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prostate Cancer (Diagnosis)
1 trial -
stereotactic body radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prostate Cancer
1 trial -
stereotactic radiosurgery
United Therapeutics Europe Ltd
Head and Neck Cancer
1 trial -
steroid therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sudden Hearing Loss
1 trial -
substructure informed planning
United Therapeutics Europe Ltd
Brain Tumor
1 trial -
succimer
Ultragenyx UK Limited
Lead Poisoning
1 trial -
telemedically guided oropharyngeal + nasal (OP+N) self-sampling (GSS) and nasopharyngeal (NP) or OP+N sampling performed by health care professionals (HCP)
Praxis Precision Medicines
Telemedicine
1 trial -
telmisartan
The First People's Hospital of Lianyungang
Hypertension
1 trial -
tested formula with fiber
United Therapeutics Europe Ltd
Atopic Dermatitis
1 trial -
therapeutic progesterone
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
thioctic acid
Ultragenyx UK Limited
Mitochondrial Myopathy
1 trial -
thyrotropin-releasing hormone
Ultragenyx UK Limited
Respiratory Distress Syndrome
1 trial -
tiered/titrated vitamin D dosing
BRIGHT MINDS BIOSCIENCES INC.
HIV-associated Co-morbidities
1 trial -
treatment with or without colistin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carbapenem-Resistant Enterobacteriaceae Infection
1 trial -
white wine
United Therapeutics Europe Ltd
Unspecified Adult Solid Tumor, Protocol Specific
1 trial -
zanubrutinib 160 mg BID orally
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma
1 trial -
zoledronate therapy
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
Ξ²-hydroxy Ξ²-methylbutyrate (HMB) supplement
Chinese University of Hong Kong
Sarcopenia
1 trial -
Ξ³-globin reactivated autologous hematopoietic stem cells
The First People's Hospital of Lianyungang
Thalassemia Major
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources